Overview
ProteomEdge develops multiplex panels of isotope-labeled protein standards for absolute protein quantification using mass spectrometry. Their products support biomarker research and translational applications in blood-based proteomics for pharma and life sciences. The company offers DiscoveryEdge 600 and plans additional targeted panels and expanded discovery products in early 2026.
Frequently asked questions
- What products does ProteomEdge offer for protein quantification?
- ProteomEdge provides multiplex panels of isotope-labeled protein standards, including DiscoveryEdge 600, for absolute quantification via mass spectrometry in biomarker research and blood proteomics.
- What are ProteomEdge's key capabilities in mass spectrometry?
- They develop proprietary MS-based analysis platforms delivering state-of-the-art accuracy for precise, scalable measurement of clinically relevant proteins.
- Where is ProteomEdge located and what is their background?
- ProteomEdge is based in Stockholm, Sweden, founded in 2023 by researchers from the Human Protein Atlas and SciLifeLab.